• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy.

作者信息

Hubbard S M, Barkes P, Young R C

出版信息

Cancer Treat Rep. 1978 Sep;62(9):1375-7.

PMID:688281
Abstract
摘要

相似文献

1
Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy.阿霉素治疗化疗后复发的晚期卵巢癌。
Cancer Treat Rep. 1978 Sep;62(9):1375-7.
2
Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.
Surg Gynecol Obstet. 1975 Dec;141(6):899-902.
3
[Preliminary report on the treatment of ovarian cancer with adriamycin following full conventional treatment (author's transl)].全常规治疗后用阿霉素治疗卵巢癌的初步报告（作者译）
Geburtshilfe Frauenheilkd. 1977 Mar;37(3):224-7.
4
Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.阿霉素与阿霉素加美法仑治疗晚期卵巢癌的对比
Cancer Treat Rep. 1977 May-Jun;61(3):355-7.
5
Medical therapy of advanced malignant epithelial tumours of the ovary.晚期卵巢恶性上皮性肿瘤的医学治疗
Forum (Genova). 2000 Oct-Dec;10(4):323-32.
6
[A combination of cyclophosphamide, adriamycin and platinum (CAP) in the treatment of stage III and IV ovarian cancer].环磷酰胺、阿霉素与铂联合（CAP）治疗Ⅲ期和Ⅳ期卵巢癌
Jugosl Ginekol Perinatol. 1988 Jan-Apr;28(1-2):41-3.
7
[Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
Wien Klin Wochenschr Suppl. 1990;183:3-29.
8
Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients.对于减瘤不充分的晚期上皮性卵巢癌患者，在基于铂类/紫杉醇的化疗后采用聚乙二醇化脂质体阿霉素巩固治疗。
Oncologist. 2006 Apr;11(4):336-41. doi: 10.1634/theoncologist.11-4-336.
9
[Experience with adriamycin in the treatment of advanced breast and ovarian cancer (author's transl)].阿霉素治疗晚期乳腺癌和卵巢癌的经验（作者译）
Lijec Vjesn. 1976 Jun;98(6):313-16.
10
Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.美法仑与顺铂联合化疗作为晚期卵巢癌初始治疗的随机试验：初步及长期结果——东部肿瘤协作组E2878研究
Cancer. 1996 Feb 15;77(4):733-42.

引用本文的文献

1
Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin.聚乙二醇化脂质体阿霉素/卡铂联合方案用于在单药聚乙二醇化脂质体阿霉素治疗期间病情进展的卵巢癌患者
World J Clin Oncol. 2012 Oct 10;3(10):137-41. doi: 10.5306/wjco.v3.i10.137.
2
A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer.一项关于聚乙二醇化脂质体阿霉素（多美素）、卡铂和紫杉醇联合用药治疗卵巢癌的I期剂量探索研究。
Br J Cancer. 2002 May 6;86(9):1379-84. doi: 10.1038/sj.bjc.6600250.
3
Developing new drugs for ovarian cancer: a challenging task in a changing reality.
开发卵巢癌新药：在不断变化的现实中的一项具有挑战性的任务。
J Cancer Res Clin Oncol. 1984;107(2):111-24. doi: 10.1007/BF00399382.
4
Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.通过人类肿瘤干细胞检测指导的卵巢癌化疗。
Cancer Chemother Pharmacol. 1981;6(3):279-85. doi: 10.1007/BF00256981.
5
Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.利用一系列哺乳动物细胞系在体外鉴定具有增强细胞毒性且对阿霉素无交叉耐药性的蒽环类类似物。
Cancer Chemother Pharmacol. 1985;14(3):194-201. doi: 10.1007/BF00258115.
6
The in vitro effects and cross-resistance patterns of some novel anthracyclines.某些新型蒽环类药物的体外效应及交叉耐药模式
Br J Cancer. 1986 May;53(5):585-94. doi: 10.1038/bjc.1986.100.
7
Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.
Invest New Drugs. 1989 Nov;7(4):333-6. doi: 10.1007/BF00173763.
8
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.在晚期乳腺癌和卵巢癌患者中使用粒细胞集落刺激因子以增加阿霉素的治疗强度。
Br J Cancer. 1989 Jul;60(1):121-5. doi: 10.1038/bjc.1989.234.
9
A phase II study of oral idarubicin in advanced recurrent or refractory ovarian carcinoma.口服伊达比星治疗晚期复发性或难治性卵巢癌的II期研究。
Cancer Chemother Pharmacol. 1990;25(4):304-5. doi: 10.1007/BF00684891.
10
Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer.表柔比星（4'-脱氧多柔比星）用于未经蒽环类药物治疗的卵巢癌患者的II期研究。
Invest New Drugs. 1990 Aug;8(3):333-6. doi: 10.1007/BF00171850.